GRFS - Total Utang marang Modal Grifols Biemat
The efficiency of Grifols, S.A. (GRFS) relies on plasma collection costs and albumin production volumes, while the share price illustrated below reflects a debt load of 1.47. Grifols, S.A. (GRFS) controls a global protein processing network, serving as a key supplier of life-saving treatments. High capacity utilization is maintained through the automation of filling processes and the upgrading of purification lines at its plants.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_GRFS_-_Grifols-S.A._-_All-Debt-to-Shareholders-Equity-Ratio "GRFS (Grifols, S.A.) riwayat Total Utang marang Modal saka 04.07.2022 nganti 30.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Grifols, S.A.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Grifols, S.A.|GRFS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Grifols, S.A.|GRFS - Gunggung utang perusahaan|Utang marang nilai buku Grifols|GRFS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Grifols|Likuiditas cepet grifols.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Grifols
For Grifols, S.A. (GRFS), the debt-to-equity chart reflects the balance between borrowed funds and equity, determining the degree of financial leverage and bankruptcy risk. This ratio reveals the company's dependence on creditors, which is critical for Grifols, S.A. (GRFS) as the costs of the plasma collection center network limit scaling efficiency and create a debt load plateau.
Analisis pesaing Grifols, S.A.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ADPT (Adaptive Biotech)|Celldex (CLDX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Aurinia Corp|BCRX (BioCryst) - Total Utang marang Modal|Total Utang marang Modal veratx.com|Rasio Total Utang marang Ekuitas DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ABCL (abcellera.com)|Koefisien Total Utang marang Modal Tourmaline (TRML)|PGEN - Utang marang Ekuitas|pharming.com (PHAR) - Rasio Total Utang marang Ekuitas|Nektar Therapeutics Inc. (NKTR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Upstream Bio, Inc.|Rasio Total Utang marang Ekuitas ZBIO|Total Utang marang Modal Immunome Bio|Utang marang Ekuitas Gossamer Bio, Inc. (GOSS)|kalvista.com - Rasio Utang marang Ekuitas|Total Utang marang Modal SEPN (Septerna)|Pieris Pharma (PVLA) - Utang marang Modal|Savara Corp - Total Utang marang Modal|Rasio Utang marang Modal Rigel Corp (RIGL)|AnaptysBio, Inc. (ANAB) - Utang marang Ekuitas|astriatx.com - Rasio Kabeh Utang marang Dana Pribadi|ENGN (enGene) - Total Utang marang Modal|RAPT Therapeutics Inc. (RAPT) - Koefisien Total Utang marang Modal|Total Utang marang Modal JBIO|ACRS: Utang Agregat marang Ekuitas|Utang marang Ekuitas Kyverna Therapeutics KYTX|tizianalifesciences.com (TLSA) - Utang marang Modal|CABA - Utang marang Ekuitas|VTYX: Utang marang Ekuitas|Theratechnologies Inc (THTX) - Utang marang Ekuitas|AVTX - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas ELDN|AGEN: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Climb Bio (CLYM)|Koefisien Total Utang marang Modal Zura Bio Ltd|aTyr - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Adagene Inc (ADAG)|Ikena Oncology, Inc. - Total Utang marang Modal|STTK - Total Utang marang Modal|EQ (equilliumbio.com) - Rasio Total Utang marang Ekuitas|CNTB - Koefisien Total Utang marang Modal|IMUX (Immunic Therapeutics) - Total Utang marang Modal|ATRA - Rasio Utang marang Modal|Utang marang Ekuitas InflaRx N.V. (IFRX)|XFOR (x4pharma.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Utang Agregat marang Ekuitas|INMB - Utang marang Ekuitas|Koefisien Total Utang marang Modal Barinthus Biotherapeutics Corp BRNS|Kezar Life Sciences (KZR) - Utang marang Ekuitas|Utang Agregat marang Ekuitas SABS (sabbiotherapeutics.com)|AKTX (Akari Therapeutics Plc) - Total Utang marang Modal|ENLV: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal QTTB|Total Utang marang Modal GeoVax Corp (GOVX)|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|Rasio Kabeh Utang marang Dana Pribadi IBIO|CARM - Utang marang Ekuitas|XTL Biopharmaceuticals Ltd (XTLB) - Rasio Total Utang marang Ekuitas|BOLT: Total Utang marang Modal|HCW Biologics (HCWB) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas APVO|AIM: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ADTX|Koefisien Total Utang marang Modal GRI Bio Inc|Utang marang Ekuitas XORTX XRTX|HIND - Rasio Total Utang marang Ekuitas|REVB - Utang marang Ekuitas|indaptusrx.com (INDP) - Rasio Total Utang marang Ekuitas|SCNI (Scinai Immunotherapeutics Ltd.) - Rasio Total Utang marang Ekuitas|CalciMedica (CALI) - Total Utang marang Modal|Utang marang Ekuitas Affimed NV|Rasio Utang marang Ekuitas ALLK (Allakos Therapeutics)|Total Utang marang Modal HOOK|IGMS - Utang marang Modal|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Rasio Utang marang Modal Ocean Biomedical Inc|TCBP - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)